Translated title of the contributionTolerability of dose-dense and standard regimens of neoadjuvant chemotherapy in estrogen receptor-positive/HER2-negative breast cancer: results of a prospective observational study
Original languageRussian
Pages (from-to)13-25
JournalПоддерживающая терапия в онкологии
Volume1
Issue number3
DOIs
StatePublished - 30 Dec 2024

ID: 146062575